Hormone Market in Singapore
Market Overview
In
, the Singaporean hormone market decreased by -
% to $
, falling for the second consecutive year after two years of growth. In general, consumption, however, showed a slight expansion. Over the period under review, the market attained the peak level at $
in 2008; however, from 2009 to
, consumption failed to regain momentum.
In value terms, hormone production expanded rapidly to $
in
estimated in export price. Overall, production, however, saw a deep setback. The most prominent rate of growth was recorded in
when the production volume increased by
%. Hormone production peaked at $
in 2009; however, from 2010 to
, production remained at a lower figure.





In value terms, hormone production expanded rapidly to $






Consumption
In
, consumption of hormones, prostaglandins, thromboxanes and leukotrienes decreased by -
% to
tons, falling for the second consecutive year after two years of growth. In general, consumption, however, continues to indicate a mild expansion. As a result, consumption attained the peak volume of
tons. From 2009 to
, the growth of the consumption failed to regain momentum.
The size of the hormone market in Singapore contracted to $
in
, with a decrease of -
% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption, however, posted a mild increase. Hormone consumption peaked at $
in 2008; however, from 2009 to
, consumption remained at a lower figure.





The size of the hormone market in Singapore contracted to $





Market Forecast
The hormone market is expected to start a downward consumption trend over the next eight-year period. The performance of the market is forecast to decrease slightly, with an anticipated CAGR of -
% for the eight-year period from
to
, which is projected to depress the market volume to
tons by the end of
.
In value terms, the market is forecast to contract with an anticipated CAGR of -
% for the period from
to
, which is projected to bring the market value to $
(in nominal prices) by the end of
.





In value terms, the market is forecast to contract with an anticipated CAGR of -





Market Structure
Hormone market in Singapore consists almost entirely of imported products. The growth in the share of Singapore imports of in the hormone market structure from
% in 2007 to
% in
is explained by a more substantial reduction in output, compared with a decrease in imports. In
, the share of imports in total consumption accounted for
% in value terms and
% in physical terms. The share of imports decreased moderately (
percentage point) over the period under review.







Trade Balance
Singapore remains a net exporter of hormone; in physical and value terms, exports consistently exceeded imports from 2007 to
. In
, there was a trade surplus of
tons, which was equal to $
. Those figures reflect the fact that neither imports nor exports don’t dominate the trade balance, and the country may export not only the product manufactured domestically, but also re-export some previously imported goods.




Download XLSX
Download all the data in the form of a report